Astria Therapeutics (ATXS) SEC Filings & 10K Form $5.18 +0.02 (+0.39%) As of 10:27 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent Astria Therapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView04/28/20253:09 PMAstria Therapeutics (Filer)Form ARS03/11/20257:07 AMAstria Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/14/20255:13 PMAstria Therapeutics (Subject)Venrock Healthcare Capital Partners III, L.P. (Filed by)Form SCHEDULE 13G/A02/14/20252:45 PMAstria Therapeutics (Subject)Fairmount Funds Management LLC (Filed by)Form SCHEDULE 13G/A02/12/20257:46 AMAstria Therapeutics (Subject)FMR LLC (Filed by)Form SCHEDULE 13G/A01/13/20257:09 AMAstria Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 01/07/20256:45 AMAstria Therapeutics (Subject)ForGrowth III PA B.V. (Filed by)Form SCHEDULE 13G11/14/20244:45 PMAstria Therapeutics (Subject)Venrock Healthcare Capital Partners III, L.P. (Filed by)Form SC 13G/A11/14/20244:46 PMAstria Therapeutics (Subject)RA CAPITAL MANAGEMENT, L.P. (Filed by)Form SC 13G/A11/14/202411:03 AMAstria Therapeutics (Subject)Vestal Point Capital, LP (Filed by)Form SC 13G11/13/20243:01 PMAstria Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 11/12/202412:29 PMAstria Therapeutics (Subject)VANGUARD GROUP INC (Filed by)Form SC 13G/A11/08/20241:17 PMAstria Therapeutics (Subject)BlackRock, Inc. (Filed by)Form SC 13G11/04/202411:37 AMAstria Therapeutics (Subject)VANGUARD GROUP INC (Filed by)Form SC 13G/A11/04/202410:39 AMAstria Therapeutics (Subject)VANGUARD GROUP INC (Filed by)Form SC 13G/A11/04/202410:39 AMAstria Therapeutics (Subject)VANGUARD GROUP INC (Filed by)Form SC 13G/A11/01/20243:05 PMAstria Therapeutics (Subject)INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)Form SC 13G10/24/20241:02 PMAstria Therapeutics (Subject)BlackRock, Inc. (Filed by)Form SC 13G08/12/20243:56 PMAstria Therapeutics (Filer)Form S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans 07/10/20249:10 AMAstria Therapeutics (Subject)FMR LLC (Filed by)Form SC 13G/A(Data available from 1/1/2016 forward) Related Companies and Tools Related Companies ETNB 10Q Form COLL 10Q Form MLYS 10Q Form NTLA 10Q Form SYRE 10Q Form ZYME 10Q Form RCUS 10Q Form NRIX 10Q Form CMRX 10Q Form CDMO 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:ATXS) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astria Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astria Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.